Journal of Neuroscience · 2000 · 75 citations · 43 references
Life SciencesImmunologyNeuroscienceCellular NeuroscienceNeuroimmunologyTransplant ImmunologyAntibody-mediated RejectionComplement SystemComplement-mediated InjuryNervous TissueNeuroinflammationTransplant RejectionComplement In Transplant RejectionHumoral RejectionSystemic Immune ResponseT Cell-dependent ActivationT Cell-mediated Immune ResponseT-cell Mediated Immune ResponseT-cell Mediated ResponsesXenograft Rejection
Vascularized whole organ discordant xenografts placed in the periphery are rejected by a rapid "hyperacute" process that involves preformed antibody binding to the xeno-antigens on the donor endothelial cells with complement activation. In the CNS, xenografts are classically thought to be rejected more slowly by a T-cell-dependent process. We now report that xenografts of embryonic porcine ventral mesencephalic tissue in the 6-hydroxydopamine-lesioned, nonimmunosuppressed rat induce both a humoral and a cell-mediated response. Over the first 10 d after implantation, the xenografts matured with identifiable TH neurons and pig-specific neurofilament fibers extending along host white matter tracts. During this period of time, IgM and complement binding were observed within the graft, as well as a CD8 cellular infiltrate, leading to rejection of the transplant over the next 25 d. These intracerebral xenografts were not associated with an early systemic antibody response. A role for complement in this rejection process was further investigated using cobra venom factor (CVF), which systemically depleted the rats of complement for 7 d. CVF treatment, when given in the period immediately before and after grafting, delayed but did not prevent the cellular immune response induced by the graft, demonstrating that xenografted neural tissue can activate the humoral arm of the rejection process, in particular the complement cascade. This suggests that interventions targeting this aspect of the immune rejection process may be of great importance for the future development of xenotransplantation for neurodegenerative conditions.
43
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity
Paul W. Dempsey, Michael Allison, Srinivas Akkaraju et al. · Science · 1996 · 1.2K citations
William L. Fodor, B. L. Williams, Louis A. Matis et al. · Proceedings of the National Academy of Sciences · 1994 · 348 citations
Life Sciences, Immunology, Surgery +17